They were developed with no knowledge of infectious dose, which you need to determine correlates of protection, which Joe Lapalca at NPR even reported was a buried slide in Fauci's brief on the day the Pfizer product was approved by the FDA. That's why the Emergency Use Authorization had described them as COVID-19 countermeasures. LaPalc…
They were developed with no knowledge of infectious dose, which you need to determine correlates of protection, which Joe Lapalca at NPR even reported was a buried slide in Fauci's brief on the day the Pfizer product was approved by the FDA. That's why the Emergency Use Authorization had described them as COVID-19 countermeasures. LaPalca suddenly decided to retire from NPR after reporting on the FDA approval of the Pfizer product.
They were developed with no knowledge of infectious dose, which you need to determine correlates of protection, which Joe Lapalca at NPR even reported was a buried slide in Fauci's brief on the day the Pfizer product was approved by the FDA. That's why the Emergency Use Authorization had described them as COVID-19 countermeasures. LaPalca suddenly decided to retire from NPR after reporting on the FDA approval of the Pfizer product.